Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Debates in early stage NSCLC without oncogenic drivers

Concurrent chemoradiotherapy followed by immunotherapy

Date

08 Dec 2024

Session

Debates in early stage NSCLC without oncogenic drivers

Topics

Cytotoxic Therapy;  Immunotherapy;  Radiation Oncology

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Kevin Lee Min Chua

Authors

K.L.M.L.M. Chua

Author affiliations

  • Division Of Radiation Oncology, NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Upfront surgery

Presenter: Hong Kwan Kim

Session: Debates in early stage NSCLC without oncogenic drivers

Resources:

Slides

Webcast

Q&A and discussion

Session: Debates in early stage NSCLC without oncogenic drivers

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.